Anne Marie Cook
CIK 1320559 · Chief Legal Off. & Corp. Sec. · last filed 2026-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$919.4K
Companies
4
Total Filings
31
Lifetime Open-Market Net
-$2.49M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHAT | Chief Legal Off. & Corp. Sec. | 88,660 | $10.37 | $919.4K | $0 | 4 | 2026-02-12 |
| Sage Therapeutics, Inc. (SAGE) Delisted | SVP, GC & Secretary | 24,040 | $8.68 | $208.7K | -$2.49M | 21 | 2024-08-07 |
| Aegerion Pharmaceuticals, Inc. (AEGR) Delisted | SVP, General Counsel | — | — | — | $0 | 5 | 2015-08-06 |
| VIACELL INC (VIAC) Delisted | General Counsel, SVP | — | $29.58 | — | $0 | 1 | 2007-03-09 |
Recent Filings · Page 2 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-10-21 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +2,684 | -$45.0K | EDGAR |
| 2021-06-17 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +2,856 | -$67.3K | EDGAR |
| 2021-02-12 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-30 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-14 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-07-29 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +1,056 | -$136.2K | EDGAR |
| 2019-06-25 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-10 | Sage Therapeutics, Inc. (SAGE) Delisted | Mixed | +700 | -$2.02M | EDGAR |
| 2019-02-15 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-11 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.